Recent News Releases

Sep 24, 2020
InMed Announces Completion of Subject Treatments in Second Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects

InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN) (OTCQX: IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and...

Sep 22, 2020
InMed Pharmaceuticals Announces Additional IntegraSyn™ Patent Filing

InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN) (OTCQX:IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and...

Sep 8, 2020
InMed Pharmaceuticals Reports Full Year Fiscal 2020 Financial Results and Provides Business Update

InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and...

Sep 2, 2020
InMed Pharmaceuticals to Report Full Year Fiscal 2020 Financial Results and Business Update on September 8, 2020

InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN) (OTCQX: IMLFF), a clinical stage pharmaceutical company developing medications targeting diseases with high unmet medical need and...

See All News Releases

Latest Presentation

Unlocking the Potential of Cannabinoid Medicines

Download pdf

Letter to Shareholders

Annual Letter to Shareholders 2020

January 17, 2020

Download pdf

SEDAR® Filings
Loading data...
Financial Reports

Quarterly and Annual Financial Results

2020

AGM Documents
Fourth quarter, 2020 (full year ended June 30, 2020)
Third quarter, 2020 (quarter ended March 31, 2020)
Second quarter, 2020 (quarter ended December 31, 2019)
First quarter, 2020 (quarter ended September 30, 2019)

2019

AGM Documents
Fourth quarter, 2019 (full year ended June 30, 2019)
Third quarter, 2019 (quarter ended March 31, 2019)
Second quarter, 2019 (quarter ended December 31, 2018)
First quarter, 2019 (quarter ended September 30, 2018)

2018

AGM Documents
Fourth quarter, 2018 (full year ended June 30, 2018)
Third quarter, 2018 (quarter ended March 31, 2018)
Second quarter, 2018 (quarter ended December 31, 2017)
First quarter, 2018 (quarter ended September 30, 2017)

2017

Fourth quarter, 2017 (full year ended June 30, 2017)
Third quarter, 2017 (quarter ended March 31, 2017)
Second quarter, 2017 (quarter ended December 31, 2016)
First quarter, 2017 (quarter ended September 30, 2016)

Stock Performance

OTCQX: IMLFFTSX: IN
-
Loading...
Display Events
 
 
 
 
Chart Style
Currency in USD.
Quote data delayed by at least 15 minutes.
Earnings Events data provided by Wall Street Horizon.
OTCQX: IMLFFTSX: IN
Analyst Coverage
Firm Analyst E-mail Phone
Edison Investment Research Max Jacobs MJacobs@edisongroup.com +1 (646) 653-7027
Maxim Group, LLC Jason McCarthy, Ph.D. jmccarthy@maximgrp.com +1 (212) 895-3556
ROTH Capital Partners Scott R. Henry, CFA shenry@roth.com +1 (406) 425-0563